Axa S.A. Invests $711,000 in Lantheus Holdings, Inc. (NASDAQ:LNTH)

Axa S.A. purchased a new position in Lantheus Holdings, Inc. (NASDAQ:LNTH – Get Rating) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 10,100 shares of the medical equipment provider’s stock, valued at approximately $711,000.

Other institutional investors also recently modified their holdings of the company. CWM LLC grew its stake in shares of Lantheus by 82.1% in the third quarter. CWM LLC now owns 366 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 165 shares during the period. Wipfli Financial Advisors LLC purchased a new position in Lantheus during the third quarter valued at approximately $30,000. Focused Wealth Management Inc bought a new stake in shares of Lantheus during the third quarter valued at approximately $63,000. Financial Gravity Asset Management Inc. bought a new stake in Lantheus in the second quarter worth $2,319,000. Finally, Quadrant Capital Group LLC increased its position in Lantheus by 435.6% in the third quarter. Quadrant Capital Group LLC now owns 1,473 shares of the medical equipment provider’s stock worth $104,000 after purchasing an additional 1,198 shares during the last quarter. 97.62% of the stock is currently owned by institutional investors.

Get Lantheus alerts:

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. StockNews.com cut shares of Lantheus from a “buy” rating to a “hold” rating in a research report on Monday. SVB Leerink assumed coverage on shares of Lantheus in a research note on Wednesday, November 30th. They issued an “outperform” rating for the company. Finally, Mizuho upped their price objective on shares of Lantheus from $105.00 to $115.00 and gave the stock a “buy” rating in a research note on Friday, February 24th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $104.80.

Lantheus Stock Performance

LNTH stock opened at $73.96 on Wednesday. The firm has a market cap of $5.00 billion, a price-to-earnings ratio of 217.53 and a beta of 0.79. The firm has a 50-day simple moving average of $55.61 and a two-hundred day simple moving average of $64.53. Lantheus Holdings, Inc. has a one year low of $46.49 and a one year high of $87.47. The company has a debt-to-equity ratio of 1.25, a quick ratio of 2.59 and a current ratio of 2.74.

Lantheus Profile

(Get Rating)

Lantheus Holdings, Inc engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments.

Further Reading

• Get a free copy of the StockNews.com research report on Lantheus (LNTH)
• Will Q4 Results Send Zoom Video Stock Higher? 
• Is Amazon a Blue Chip Stock?
• Occidental Petroleum Pulls Back To The Sweet Spot
• Should You Take a Cruise in Royal Caribbean Stock?
• Is Target Stock Aiming For A Breakout In 2023? 

Want to see what other hedge funds are holding LNTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lantheus Holdings, Inc. (NASDAQ:LNTH – Get Rating).

Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.